Potential coronavirus treatment granted rare disease status

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

WASHINGTON — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales. What that specialty status will actually mean for the marketing or profitability of Gilead Science's experimental drug remdesivir isn't clear. The drugmaker did not immediately respond Tuesday to requests for comment. Experts who have studied the so-called “orphan drug” program say the company's request — and the Food and Drug Administration's decision to grant it — seem inappropriate given the rapidly expanding threat of the viral outbreak. A financial analyst, though, called Gilead's request “pretty standard.” The FDA granted the status on Monday, according to the agency's website. If approved for coronavirus, Gilead Sciences would receive seven years of exclusive U.S. marketing for the drug and tax credits on its research and development costs. Congress created the orphan drug program more than 35 years ago to encourage companies to develop drugs for niche diseases and conditions that might not otherwise be profitable. But since then, filing for orphan status has become a standard pharmaceutical industry tactic to extend the profitability of drugs and block competitors. Orphan drugs are also typically eligible for other special programs that speed up FDA reviews for approval. The FDA defines a rare disease as one with fewer than 200,000 patients in the U.S. In a statement Tuesday, the agency said COVID-19 fit that criteria when the request was made. There are more than 50,000 cases in U.S. but many more expected in the coming weeks and months. “It seems like a misuse of the Orphan Drug Act, even though technically it’s within the bounds of the law,” said Dr. Aaron Kesselheim, a Harvard Medical School health policy expert. “There’s no expectation here that this drug wouldn’t be able to generate appropriate revenue for the manufacturer.” Kesselheim said a number of the early AIDS drugs also received orphan drug status in the 1980s and 1990s, but then went on to generate billions in sales. But Tyler Van Buren, a senior research analyst at the financial services firm Piper Sandler, called Gilead's filing “pretty standard.” “It says nothing about profiting off of the pandemic, but it does provide protection if remdesivir turns into a business in subsequent years," he said. In recent years the orphan drug program has come under scrutiny from the media, Congress and government inspectors amid concerns that it is being misused to protect six-figure prices on specialty drugs. Roughly half of the 48 new drugs approved by the agency last year received orphan drug designation. Many were priced well above $100,000 for a year's supply, including drugs for cancer, muscular dystrophy and other genetic disorders. The nonprofit Public Citizen group said in a statement that the U.S. government should be “urgently concerned” with the affordability of remdesivir. Gilead's chairman and CEO, Daniel O'Day has previously said the company hasn’t discussed with any governments how much remdesivir will cost. “The topic of pricing comes up once you know the medicine works,” he said. Remdesivir, given through an IV, is being tested in at least five separate experiments, and Gilead also has provided it to several hundred severely ill COVID-19 patients in the U.S, Europe and Japan under "compassionate use" provisions. The company said Sunday it was halting that program due to an unmanageable number of requests. The drug interferes with virus reproduction and has shown some promise in lab and animal studies against other coronaviruses that cause similar diseases, MERS and SARS. It was also used briefly in some Ebola patients in Congo. For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The vast majority of people recover. Day said earlier this month at a press conference with other drug industry executives that his company has been working on the drug's development for a decade. He said Gilead has spent “really billions of dollars” developing the drug and plans to spend even more to scale up manufacturing facilities at Gilead and its partners. Gilead didn’t respond to questions seeking more details about the company’s spending on remdesivir, including whether the figures used by O’Day included the U.S. government money spent on research by federal scientists and grants to universities.

Other articles published by Las Vegas Sun

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

Since the first person tested positive for the coronavirus in Nevada, the pathogen has swept Southern Nevada with alarming speed — from one to two cases, then a few dozen and then a couple hundred. By the time you read this, the number will certainly...

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

Awaiting a COVID-19 test result, Shira has been isolated in her Henderson home since Sunday. Unable to spend time with her family until she receives the results of her test in a few days, she did her best to celebrate her daughter’s birthday on Monday, ...

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

It was a simple, yet powerful message from a high school student-athlete: “You can’t win a game by yourself,” the Spring Valley High flag football player said. One by one, students in Billy Hemberger’s sports leadership course at Spring Valley...

There’s no time to waste Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

We have heard over and over again that the stock market hates uncertainty. Humans likewise hate uncertainty. However, today, both our lives and our economy are more uncertain than ever. If this is “war,” then let’s spend as if it were. This is no...

President just passes the buck Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

I am amazed at how often President Donald Trump, in the public arena, blames others as part of his explanation of whatever topic he has on his mind. Recently, the topic has been mostly the coronavirus pandemic. If Trump gets any pushback from reporters,...

Utility workers being responsible Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

I’m a lineman for NV Energy. I’m not a spokesperson, just an average guy, just doing my part to keep the power on. I want to let the public know that NVEnergy has taken a proactive approach to provide reliable of service during the pandemic. My union ...

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

Zach Whitecloud signed a two-year extension with the Golden Knights on Sunday, securing the 23-year-old defenseman’s future with the team through the summer of 2022. Even when his contract expires, however, Whitecloud likely isn’t going anywhere....

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

LOS ANGELES — Los Angeles County health officials backtracked Tuesday on their announcement that a child died from coronavirus, saying it’s possible the death was caused by something else. During their daily briefing, the county health department...

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

YPSILANTI, Mich. — Washtenaw Golf Club, one of the oldest courses in Michigan, typically only has to worry about the weather in March. Now there is a far more serious issue to contemplate: the new coronavirus. "This is the one thing we didn't think...

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

Trevor May has been preparing for this. Not precisely for a global pandemic that would bring sports — and so much else — to an unprecedented standstill. Even hours and hours of dystopian video games couldn't help foresee that. But a break in the...

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

WASHINGTON — The State Department has advised against all international travel because of the coronavirus, but that didn't stop Secretary of State Mike Pompeo from flying to Afghanistan this week. Gyms across the nation's capital are shuttered, but...

South Korea investigates chatroom sex abuse allegations Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

SEOUL, South Korea — South Korean prosecutors on Wednesday began reviewing whether to formally charge a man arrested last week on allegations that he operated secret chatrooms where he posted sexually abusive videos of blackmailed women in return for...

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

NEW DELHI — The world's largest democracy went under the world's biggest lockdown Wednesday, with India's 1.3 billion people ordered to stay home in a bid to stop the coronavirus pandemic from spreading and overwhelming its fragile health care system...

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

For Anna, a 33-year-old American woman stranded in a Peruvian hotel room and out of life-saving medication to treat her auto-immune disease, the clock is ticking. After Peru ordered its borders closed March 15 in an effort to hinder the spread of the new ...

Posted Wednesday, 25 March 2020 ‐ Las Vegas Sun

STORRS, Conn. — All but one of Anna Makurat's teammates headed home after the NCAA canceled this year's postseason basketball tournament and the school suspended classes amid the COVID-19 pandemic. For the 19-year-old UConn freshman from Poland, the...